Literature DB >> 14724276

Peroxidase activity of cyclooxygenase-2 (COX-2) cross-links beta-amyloid (Abeta) and generates Abeta-COX-2 hetero-oligomers that are increased in Alzheimer's disease.

Seiichi Nagano1, Xudong Huang, Robert D Moir, Sandra M Payton, Rudolph E Tanzi, Ashley I Bush.   

Abstract

Oxidative stress is associated with the neuropathology of Alzheimer's disease. We have previously shown that human Abeta has the ability to reduce Fe(III) and Cu(II) and produce hydrogen peroxide coupled with these metals, which is correlated with toxicity against primary neuronal cells. Cyclooxygenase (COX)-2 expression is linked to the progression and severity of pathology in AD. COX is a heme-containing enzyme that produces prostaglandins, and the enzyme also possesses peroxidase activity. Here we investigated the possibility of direct interaction between human Abeta and COX-2 being mediated by the peroxidase activity. Human Abeta formed dimers when it was reacted with COX-2 and hydrogen peroxide. Moreover, the peptide formed a cross-linked complex directly with COX-2. Such cross-linking was not observed with rat Abeta, and the sole tyrosine residue specific for human Abeta might therefore be the site of cross-linking. Similar complexes of Abeta and COX-2 were detected in post-mortem brain samples in greater amounts in AD tissue than in age-matched controls. COX-2-mediated cross-linking may inhibit Abeta catabolism and possibly generate toxic intracellular forms of oligomeric Abeta.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724276     DOI: 10.1074/jbc.M313003200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

2.  Cyclooxygenase-2 is critical for the propagation of β-amyloid protein and reducing the glycosylation of tau in Alzheimer's disease.

Authors:  Pei-Pei Guan; Xin Yu; Yan-Hui Zou; Pu Wang
Journal:  Cell Mol Immunol       Date:  2019-09-24       Impact factor: 11.530

3.  Age-dependent effect of apolipoprotein E4 on functional outcome after controlled cortical impact in mice.

Authors:  Rebekah C Mannix; Jimmy Zhang; Juyeon Park; Xuan Zhang; Kiran Bilal; Kendall Walker; Rudolph E Tanzi; Giuseppina Tesco; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-30       Impact factor: 6.200

4.  Cyclooxygenase-2 Induced the β-Amyloid Protein Deposition and Neuronal Apoptosis Via Upregulating the Synthesis of Prostaglandin E2 and 15-Deoxy-Δ12,14-prostaglandin J2.

Authors:  Pei-Pei Guan; Yun-Yue Liang; Long-Long Cao; Xin Yu; Pu Wang
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 5.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

6.  Viewpoints on Acid-induced inflammatory mediators in esophageal mucosa.

Authors:  Karen M Harnett; Florian Rieder; Jose Behar; Piero Biancani
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

7.  HCl-activated neural and epithelial vanilloid receptors (TRPV1) in cat esophageal mucosa.

Authors:  Ling Cheng; Suzanne de la Monte; Jie Ma; Jie Hong; Ming Tong; Weibiao Cao; Jose Behar; Piero Biancani; Karen M Harnett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-23       Impact factor: 4.052

8.  Peroxidative aggregation of alpha-synuclein requires tyrosines.

Authors:  Alina Olteanu; Gary J Pielak
Journal:  Protein Sci       Date:  2004-09-30       Impact factor: 6.725

Review 9.  Therapeutics for Alzheimer's disease based on the metal hypothesis.

Authors:  Ashley I Bush; Rudolph E Tanzi
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

10.  Eicosanoid production varies by sex in mesenteric ischemia reperfusion injury.

Authors:  Miaomiao Wu; Jennifer M Rowe; Sherry D Fleming
Journal:  Clin Immunol       Date:  2020-09-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.